{"id":"W4286296447","doi":"10.1200/jco.2022.40.16_suppl.4561","title":"Health-related quality of life (HRQoL) for patients with advanced/metastatic urothelial carcinoma (UC) enrolled in KEYNOTE-052 who are potentially platinum ineligible.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Discontinuation; Quality of life (healthcare); Pembrolizumab; Cisplatin; Nausea; Internal medicine; Performance status; Oncology; Clinical trial; Tolerability; Visual analogue scale; Carboplatin; Chemotherapy; Cancer; Surgery; Adverse effect; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001110601,0.0003500573,0.0005502788,0.0002433187,0.0002228566,0.0006474689,0.0003274538,0.0004346655,0.003294471],"category_scores_gemma":[0.001349684,0.0001426803,0.001075588,0.0005220643,0.0001851237,0.0006402401,0.0006346932,0.0007744398,0.0003179019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004236014,"about_ca_system_score_gemma":0.0003605796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003803467,"about_ca_topic_score_gemma":0.0008365987,"domain_scores_codex":[0.9995766,0.000134539,0.00004297018,0.000102057,0.0000535486,0.00009030731],"domain_scores_gemma":[0.99932,0.00009581118,0.0003066417,0.00004470104,0.0000349576,0.0001978985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1313969,0.006998001,0.8021802,0.0008647614,0.002220259,0.0003047338,0.0002403369,0.001806297,0.004706052,0.0002179591,0.00363686,0.0454276],"study_design_scores_gemma":[0.007125069,0.04767547,0.9380876,0.00007464214,0.001140933,0.0004244948,0.0002045137,0.001470597,0.001283948,0.0001749722,0.002307744,0.00003011208],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996849,0.0006516768,0.00006995905,0.00008055792,0.00001116705,0.00009779465,0.001645897,0.000004935256,0.0005890591],"genre_scores_gemma":[0.997461,0.0001257499,0.0001038109,0.00008631423,0.0000115873,0.00009664467,0.00191597,9.047223e-7,0.0001981296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003294471,"threshold_uncertainty_score":0.01102108,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09338075154397162,"score_gpt":0.4274998481295275,"score_spread":0.3341190965855559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}